Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

The design of potent, non-peptidic inhibitors of hepatitis C protease

By Andrews D.M.   Chaignot H.M.   Coomber B.A.   Dowle M.D.   Lucy Hind S.   Johnson M.R.   Jones P.S.   Mills G.   Patikis A.   Pateman T.J.   Ed Robinson J.   Slater M.J.   Trivedi N.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 339-343

Elsevier

Access to resources Recommend Favorite

Hepatitis C Virus Serine Protease Inhibitors: Current Progress and Future Challenges

By  

Current Medicinal Chemistry, Vol. 8, Iss. 8, 2001-07 ,pp. : 919-932

Bentham Science Publishers

Access to resources Recommend Favorite

Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Dynamics and Structure-based Design of Drugs Targeting the Critical Serine Protease of the Hepatitis C Virus - From a Peptidic Substrate to BILN 2061

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 111-132

Bentham Science Publishers

Access to resources Recommend Favorite